US › Healthcare

IRIDEX Corporation (IRIX)

US · Healthcare · Medical Devices

$0.82-0.58%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$11.8M
Revenue YoY
-0.8%
Net profit
$-524,000
Profit YoY
+68.9%
EPS
$-0.03
EPS estimate
$-0.07
Net margin
-4.4%

EPS came in at -0.03 against a street estimate of -0.07 — a beat of 57.1%.

Key statistics

Market cap
$14.4M
Forward P/E
769.2
P/B
331.20
Book value
$-0.07
EPS (TTM)
$-0.19
52-week high
$1.65
52-week low
$0.80
50-day MA
$1.06
200-day MA
$1.14
Beta
0.64

Analyst view

with an average price target of $2.75.

Shareholding

Insiders
37.07%
Institutions
17.94%

Largest institutional holders

FundStake
PARAGON Assoc & PARAGON Assoc II JV5.75%
Vanguard Capital Management, LLC2.96%
Renaissance Technologies Corp2.28%
Weber Capital Management LLC1.49%
Geode Capital Management, LLC0.92%
Citadel Advisors Llc0.35%
Vanguard Fiduciary Trust Co0.35%
United Capital Financial Advisers Inc0.33%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for IRIDEX Corporation — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.